Trials / Completed
CompletedNCT00226460
Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Genzyme, a Sanofi Company · Industry
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to evaluate the differences in safety and efficacy between Parkinson's disease patients who either received transplantation of fetal porcine cells or placebo treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fetal porcine cells, Neurocell-PD |
Timeline
- Start date
- 1997-08-01
- Completion
- 2001-01-01
- First posted
- 2005-09-27
- Last updated
- 2015-03-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00226460. Inclusion in this directory is not an endorsement.